Home › Funds › Bellevue Group AG › ELV

Bellevue Group AG position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Bellevue Group AG reported holding 56,449 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$21.8M, representing 0.46% of its reported portfolio and ranking #49 among its reported holdings. Bellevue Group AG has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)56.45K sh
Reported value held$21.83M
Portfolio Weight0.46%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's ELV position evolved

Bellevue Group AG first disclosed a stake in ELV in Q3 2023 at 173,887 shares (US$75.7M). Across 12 filings, Bellevue Group AG increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 56,449 shares valued at US$21.8M — an increase of 3,931 shares quarter over quarter.. Notable position changes include a 38% trim in Q4 2023 (shares rose 10% over the following quarter), a 57% trim in Q4 2024 (shares rose 18% over the following quarter), a 105% increase in Q2 2025 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 173.89K $75.71M New
Q4 2023 107.79K $50.83M Reduce
Q1 2024 98.61K $51.13M Reduce
Q2 2024 101.55K $55.03M Add
Q3 2024 89.33K $46.45M Reduce
Q4 2024 38.34K $14.14M Reduce
Q1 2025 40.06K $17.42M Add
Q2 2025 82.05K $31.92M Add
Q3 2025 104.97K $33.92M Add
Q4 2025 69.64K $24.41M Reduce
Q1 2026 52.52K $15.37M Reduce
Q2 2026 56.45K $21.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Bellevue Group AG held ELV?

Bellevue Group AG has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bellevue Group AG's current position in ELV?

As of Q2 2026, Bellevue Group AG holds 56.45K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $21.83M, representing 0.46% of its reported portfolio and ranking #49.

Has Bellevue Group AG been buying or selling ELV?

In the latest 13F filing (Q2 2026), Bellevue Group AG increased its position in ELV.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.